Tongling Jieya Biologic Technology (301108.SZ) issued a profit warning, estimating a net profit of 15 million to 22.5 million yuan for the year 2024, a year-on-year decrease of 86.98% to 80.47%.
Jieya Co., Ltd. (301108.SZ) announced its annual performance forecast for 2024. The company is expected to achieve a...
Tongling Jieya Biologic Technology (301108.SZ) released its 2024 annual performance forecast, with the company expecting a net profit attributable to shareholders of the listed company of 15-22.5 million yuan in 2024, a year-on-year decrease of 86.98%-80.47%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
